80
55
Growth Score
-7 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1915452
GPC Biotech is a German biopharmaceutical company that discovers and develops anticancer drugs.
About the Company
GPC Biotech is a German biopharmaceutical company that discovers and develops anticancer drugs. The company’s product portfolio includes Satraplatin, a platinum-based small molecule for prostate cancer; MAb 1D09C3, a monoclonal antibody for lymphoma; and RGB-286199, a small molecule for refractory cancer.
In March 2000, the company acquired
Mitotix, Inc., an American drug discovery and development company focused on treatments for cancer and fungal infections.
GPC Biotech was founded in 1997 and currently operates as a subsidiary of Agennix AG.
